ArticleBMC neurology2025

A real-world retrospective study to assess the effectiveness and safety profile of siponimod in Chinese patients with relapsing forms of multiple sclerosis.

Yao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.